Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia.

Trial Profile

Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2013

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Friedreich's ataxia; Machado-Joseph Disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Planned End Date changed from 1 Mar 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 09 Sep 2011 Actual initiation date Aug 2011 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top